![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » NeuroOne’s Brain Stimulation Electrode Cleared
NeuroOne’s Brain Stimulation Electrode Cleared
![FDA clears text](https://www.fdanews.com/ext/resources/test/Drug-Images4/FDA-clears.gif?t=1619732616&width=430)
NeuroOne Medical has received the FDA’s 510(k) clearance for its Evo sEEG electrode technology for temporary use — for less than 24 hours — for recording, monitoring and stimulation of electrical signals in the brain.
Less invasive than cortical electrodes, the sEEG electrodes provide a similar function but do not require removal of the top portion of the patient's skull.
The company, which plans to seek expanded clearance for longer-term use, is developing permanently implanted stimulation electrodes for patients with chronic conditions, such as epilepsy, Parkinson's disease and chronic back pain.
Upcoming Events
-
11Jul
-
18Jul
-
21Oct